Elutia/$ELUT
1D1W1MYTD1Y5YMAX
About Elutia
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
- Ticker
- $ELUT
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 26
- Headquarters
- Gaithersburg, United States
- Website
- elutia.com
Elutia Metrics
BasicAdvanced
$39M
0.87
$1.01
0.88
-
Price and volume
Market cap
$39M
Beta
0.88
52-week high
$2.38
52-week low
$0.50
Average daily volume
58K
Financial strength
Current ratio
1.768
Quick ratio
1.014
Long term debt to equity
23.466
Total debt to equity
27.817
Profitability
EBITDA (TTM)
-21.353
Gross margin (TTM)
57.76%
Net profit margin (TTM)
426.90%
Operating margin (TTM)
-177.06%
Effective tax rate (TTM)
-0.34%
Revenue per employee (TTM)
$470,000
Management effectiveness
Return on assets (TTM)
-34.66%
Return on equity (TTM)
171.92%
Valuation
Price to earnings (TTM)
0.875
Price to revenue (TTM)
3.126
Price to book
2.48
Price to tangible book (TTM)
2.64
Price to free cash flow (TTM)
-0.824
Free cash flow yield (TTM)
-121.33%
Free cash flow per share (TTM)
-1.068
Growth
Revenue change (TTM)
-0.33%
Earnings per share change (TTM)
-189.32%
3-year revenue growth (CAGR)
-21.59%
3-year earnings per share growth (CAGR)
-23.45%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.